Unknown

Dataset Information

0

Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD.


ABSTRACT: We studied 11 new kindreds with primary pigmented nodular adrenocortical disease (PPNAD) or Carney complex (CNC) and found that 82% of the kindreds had PRKAR1A gene defects (including seven novel inactivating mutations), most of which led to nonsense mRNA and, thus, were not expressed in patients' cells. However, a previously undescribed base substitution in intron 6 (exon 6 IVS +1G-->T) led to exon 6 skipping and an expressed shorter PRKAR1A protein. The mutant protein was present in patients' leukocytes and tumors, and in vitro studies indicated that the mutant PRKAR1A activated cAMP-dependent protein kinase A (PKA) signaling at the nuclear level. This is the first demonstration of an inactivating PRKAR1A mutation being expressed at the protein level and leading to stimulation of the PKA pathway in CNC patients. Along with the lack of allelic loss at the PRKAR1A locus in most of the tumors from this kindred, these data suggest that alteration of PRKAR1A function (not only its complete loss) is sufficient for augmenting PKA activity leading to tumorigenesis in tissues affected by CNC.

SUBMITTER: Groussin L 

PROVIDER: S-EPMC378588 | biostudies-literature | 2002 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD.

Groussin Lionel L   Kirschner Lawrence S LS   Vincent-Dejean Caroline C   Perlemoine Karine K   Jullian Eric E   Delemer Brigitte B   Zacharieva Sabina S   Pignatelli Duarte D   Carney J Aidan JA   Luton Jean Pierre JP   Bertagna Xavier X   Stratakis Constantine A CA   Bertherat Jérôme J  

American journal of human genetics 20021106 6


We studied 11 new kindreds with primary pigmented nodular adrenocortical disease (PPNAD) or Carney complex (CNC) and found that 82% of the kindreds had PRKAR1A gene defects (including seven novel inactivating mutations), most of which led to nonsense mRNA and, thus, were not expressed in patients' cells. However, a previously undescribed base substitution in intron 6 (exon 6 IVS +1G-->T) led to exon 6 skipping and an expressed shorter PRKAR1A protein. The mutant protein was present in patients'  ...[more]

Similar Datasets

| S-EPMC2805491 | biostudies-literature
2005-03-11 | GSE2055 | GEO
| S-EPMC5033753 | biostudies-literature
2005-03-10 | E-GEOD-2055 | biostudies-arrayexpress
| S-EPMC4184389 | biostudies-literature
| S-EPMC3124768 | biostudies-literature
| S-EPMC9633213 | biostudies-literature
| S-EPMC521100 | biostudies-literature
| S-EPMC3275364 | biostudies-literature
| S-EPMC2577759 | biostudies-literature